Primary Record
FOLFIRI regimen
- In stock
- 7,134 g
- Purity
- 98.6 %
- CAS
- 1000669-05-5
Compound Identifiers & Properties
- CAS
- 1000669-05-5
- PubChem CID
- 136170999
- SMILES
- CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O.C1=C(C(=O)NC(=O)N1)F
- Canonical SMILES
- CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2.O=c1[nH]cc(F)c(=O)[nH]1
Names & Synonyms
- FOLFIRI regimen
- FOLFIRI
- FOLFIRI-cetuximab regimen
- RefChem:1085498
- DTXSID70142901
- orb1697172
- SCHEMBL5665429
- DTXCID1065392
- SCHEMBL29351287
- AKOS040751836
- 5-Fluorouracil / Folinic acid / irinotecan
- Folinic acid / 5-fluorouracil / irinotecan
- Irinotecan, Leucovorin and Fluorouracil mixture
- 1000669-05-5
- 5-Fluorouracil mixture with Folinic acid and Irinotecan
- 5-Fluorouracil mixture with Folinic acid and Irinotecan
- Leucovorin-fluorouracil-irinotecan-cetuximab regimen
- S900006140
- Cetuximab / fluorouracil / irinotecan / leucovorin regimen
- Cetuximab regimen with fluorouracil, irinotecan and Leucovorin
- Leucovorin regimen with fluorouracil, irinotecan and cetuximab
- (2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;5-fluoro-1H-pyrimidine-2,4-dione
- L-Glutamic acid, N-(4-(((2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl) methyl)amino)benzoyl)-, mixt. with (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl (1,4'-bipiperidine)-1'-carboxylate and 5-fluoro-2,4(1H,3H)-pyrimidinedione